-+ 0.00%
-+ 0.00%
-+ 0.00%

Inhibrx Biosciences FY 2025 net loss widens to USD 140.06 million as revenue rises 550% to USD 1.3 million

Reuters·03/19/2026 20:00:24

Please log in to view news